Concepedia

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Anders Åsberg, Atul Humar, Halvor Rollag, Alan G. Jardine, H. Mouas, Mark D. Pescovitz, Dino Sgarabotto, Murat Tuncer, Irene L. Noronha, Anders Hartmann

American Journal of Transplantation · 2007 · 425 citations · 20 references

DOI

Concepts

References

20

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Carlos V. Payá, Atul Humar, Ed Dominguez et al. · American Journal of Transplantation · 2004 · 884 citations · Full text

, , +17

American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation

Atul Humar, Marian G. Michaels · American Journal of Transplantation · 2006 · 488 citations

, , +17

A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis

Daniel Martín, Juan Sierra‐Madero, Sharon Walmsley et al. · New England Journal of Medicine · 2002 · 394 citations · Full text

, , +12

Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

Mark D. Pescovitz, John M. Rabkin, Robert M. Merion et al. · Antimicrobial Agents and Chemotherapy · 2000 · 363 citations

, , +15

Cytomegalovirus (CMV) DNA Load Predicts Relapsing CMV Infection after Solid Organ Transplantation

Irene G. Sia, Jennie Wilson, Cynthia Groettum et al. · The Journal of Infectious Diseases · 2000 · 222 citations · Full text

, , +13